The nation of Zimbabwe has declined a substantial American health deal worth $367m (272 million pounds) spanning five years over the United States' demand for confidential biological samples.
This rejection was revealed following a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson has since stated that the United States was demanding access to biological samples for scientific study and commercial gain while refused to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further negotiations to reach a deal agreeable to all parties so the nation's vital HIV programme can be sustained.
Broader Background
This development comes after a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement following concerns were filed about the security of citizens' medical information.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.
Based on statements, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our citizens if a future health crisis arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This framework is designed to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage further discussions with our US partners on how subsequent co-operation could be arranged in a way that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but urged that talks should continue considering much of the nation's HIV programmes relied on international support.
"Where specific concerns arise, including those involving information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
The halted deal emphasises the complex tensions between accepting much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.